Point of Care Diagnostics Market Size, Trends and Forecast 2024-2032

Comments ยท 2 Views

According to FutureWise analysis the market for point of care diagnostics in 2023 was US$ 43.34 billion, and is expected to reach US$ 72.92 billion by 2031 at a CAGR of 6.70%.

According to FutureWise analysis the market for point of care diagnostics in 2023 was US$ 43.34 billion, and is expected to reach US$ 72.92 billion by 2031 at a CAGR of 6.70%.

Point-of-care diagnostics (POCT) refers to the practice of conducting medical diagnostic tests and analyses near or at the location where a patient is receiving care, whether it's at the bedside, in a clinic, at a community health center, or even in a non-traditional healthcare setting like a pharmacy. This approach eliminates the need for samples to be transported to centralized laboratories, reducing the time between sample collection and result availability. With its quick results and versatility, POCT has found applications in diverse healthcare settings, from hospitals and clinics to remote areas and community centers. The accessibility and cost-efficiency of point-of-care testing make it a powerful tool, particularly in resource-limited settings, where timely diagnosis can be challenging. However, ensuring accurate results, proper training of healthcare staff, and careful consideration of costs remain essential factors in realizing the full potential of this approach. Overall, point-of-care diagnostics represent a significant advancement in healthcare delivery, empowering patients and healthcare professionals with immediate, actionable information for improved patient outcomes.

FutureWise Market Research has published a report that provides an insightful analysis of Point of Care Diagnostics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

Request a Free Sample @
 https://www.futurewiseresearch.com/healthcare-market-research/Point-of-Care/3441

Point of Care Diagnostics Market Segmentation:

By Product

  • Glucose Monitoring Products
    • Strips
    • Meters
    • Lancets and Lancing Platform
  • Cardiometabolic Testing Products
    • Cardia Marker Testing Products
    • Blood Gas/Electrolytes Testing Products
    • HBA1C Testing Products
  • Infectious Disease Testing Products
    • HIV testing Products
    • Hepatitis C Testing Products
    • Sexually Transmitted Disease (STD) Testing Products
    • Healthcare-Associated Infection (HAI) Testing Products
    • Respiratory Infection Testing Products
    • Tropical Disease Testing Products
    • Other Infectious Disease testing Products
  • Coagulation Testing Products
    • PT/INR Testing Products
    • Activated Clotting Time (ACT/APTT) Testing Products
  • Pregnancy and Fertility Testing Products
    • Tumour/Cancer Marker Testing Products
    • Urinalysis Testing Products
    • Cholesterol Testing Products
    • Hematology testing Products
    • Drug-of-Abuse Testing Products
    • Fecal Occult Testing Products
    • Other POC Products

By Platform

  • Agglutination Assays
  • Immunoassays
  • Biosensors
  • Dipsticks
  • Lateral Flow Assays
  • Microfluidics
  • Molecular Diagnostics
  • Solid Phase

By Mode

  • Prescription-Based Testing
  • OTC Testing

By End User

  • Home Care/ Self Testing
  • Physician Offices and Outpatient Centers
  • Hospitals
  • Research Laboratories
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Competitive Landscape in the Point of Care Diagnostics Market:

  • Abbott
  • AccuBioTech
  • BioMérieux SA
  • Bio-Rad Laboratories
  • Becton Dickinson, and Company
  • Chembio Diagnostics
  • Danaher
  • EKF Diagnostics
  • F. Hoffmann-La Roche
  • Werfen (Instrumentation Laboratory)
  • Johnson & Johnson
  • Nova
  • PTS Diagnostics
  • Sekisui Diagnostic
  • Siemens Healthineers
  • Sinocare Inc.
  • Sysmex Corporation
  • Trinity Biotech
  • Trividia Health Inc.,0
  • QIAGEN
  • Quidel

Buy now the latest version of this report:
https://www.futurewiseresearch.com/contact.aspx?rpt=3441%20&type=discount

**Objectives of this Study: **

  1. To provide a comprehensive analysis of the Point of Care Diagnostics Market By Product, By Platform, By Mode, By End User, and By Region.
  2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
  3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
  4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
  • The customization services offered are free of charge with the purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com

FutureWise Research

Contact Person: Vinay Thaploo.

Email: sales@futurewiseresearch.com

Contact Number: Asia: +91 8605575209 | USA: +1 3477094931

Website: www.futurewiseresearch.com

disclaimer
Comments